In Silico Tau Protein Kinase I Inhibitory Activity of Some Commercially Available Flavonoids

Authors

  • A. Madeswaran Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu, India
  • K. Asokkumar Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu, India

Abstract

Molecular docking is a frequently used tool in computer-aided structure-based rational drug design. Flavonoids are a group of natural products which exhibits various biological and pharmacological activities. The primary objective of this study was to investigate the tau protein kinase I inhibitory activity of flavonoids using in silico docking studies. Memantine, a known neuro-receptor antagonist is currently used in the treatment of Alzheimer’s disease (AD). In silico docking studies were carried out using AutoDock 4.2, based on the Lamarckian genetic algorithm principle. The results showed that all the selected flavonoids showed binding energy ranging between −6.98 to −5.95 kcal/mol when compared with that of the standard (−5.89 kcal/mol). Inhibition constant (7.65 to 43.64 µM) and intermolecular energy (−8.47 to −7.15 kcal/mol) of the flavonoids also coincide with the binding energy. All the selected flavonoids contributed tau protein kinase I inhibitory activity because of its structural properties. These molecular docking analyses could lead to the further development of potent tau protein kinase I inhibitors for the treatment of AD. Further investigations on the above compounds and in vivo studies are necessary to develop potential chemical entities for the prevention and treatment of AD.

 

Keywords: Alzheimer’s Disease, flavonoids, binding energy, inhibition constant, intermolecular energy

Cite this Article:

Madeswaran A, Asokkumar K. In silico tau protein kinase I inhibitory activity of some commercially available flavonoids. Research & Reviews: A Journal of Drug Design & Discovery. 2015. 2(1): 6–12p.

 

Downloads

Published

2019-03-01

Issue

Vol. 2 No. 1 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.